Scientific Executive Board
The Scientific Executive Board (SEB) is a committee which: i) develops the research strategy of CRUK for discusion with the Research Committee (a committee of Council) and recommendation for approval to Council; ii) implements the research strategy and research policy, including the scientific elements of the long term business plan and the annual scientific budget; and iii) provides advice, information and comments on research related issues to other parts of CRUK.
SEB works with: the Research Committee, particularly for the development and implementation of the scientific policy and strategy and for review of performance in this area; other Committees of Council, or other groupings; Funding Committees and specially convened expert review panels, which make funding decisions on grant applications, provide recommendations to SEB as appropriate for ratification or decision, and which require scientific information or advice in the conduct of their activities; and, the Executive Board, for the interface of scientific activities with the rest of the Charity.
SEB meets every two months and is currently chaired by Dr Iain Foulkes, Executive Director, Research & Innovation (R&I) and CEO of Cancer Research Technology (CRT).
Our Chief Scientist, Professor Karen Vousden, and Chief Clinician, Professor Charles Swanton, are also members along with the CEO and CFO.
Scientific experts are invited in to help inform discussion on particular topics.
Members of the SEB
- Nigel Armitt, Chief Finance Officer and Executive Director, Corporate Resources
- Dr Iain Foulkes, Executive Director, Research & Innovation and CEO of CRT
- Michelle Mitchell, Chief Executive
- Professor Charles Swanton, Chief Clinician
- Professor Karen Vousden, Chief Scientist
The Scientific Executive Board holds overall responsibility for Cancer Research UK's research funding, and has oversight of the funding committees who award grants for investigator-led research.
The board can also consider approaches for funding that do not fall within the scope of our existing funding committees and schemes. For example, this may be because:
- The cost exceeds the limits available to a committee
- The scope spans the remit of multiple funding committees
- An initiative involves a consortium-based approach
- There is a need to recruit international leadership in key research areas
It is rare for us to fund activity this way as most activity should be covered via our funding schemes, but approaches via this route are considered on an individual basis. In the first Instance it is recommended that you discuss ideas with Iain Foulkes, Karen Vousden or Charles Swanton.
Get in touch
If you require further information or have any comments please get in touch.